We have conducted more than 750 clinical trials, involving more than 15,000 patients/volunteers, encompassing phases I-IV, in both public- and private-sector settings. We have enjoyed numerous leading edge scientific collaborative efforts with clinicians at Universities and VA hospitals, as well as in other public and private research organizations. We are passionate in our pursuit of excellence in clinical research. Furthermore, from both a regulatory and commercial perspective, the achievements we have made here at PRI have been unmatched – when objectively measured and quantified. While we, by intent and design, do not own any stock in any sponsoring company, we have had major positive roles in the clinical evaluation and eventual commercial availability of more than 30 successfully marketed compounds, helping literally millions and millions of people all around the world!